Growth Metrics

Enovis (ENOV) Liabilities and Shareholders Equity (2010 - 2026)

Enovis (ENOV) reported Liabilities and Shareholders Equity of $3.8 billion for Q2 2026, down 21.39% year-over-year from $4.9 billion in Q2 2025, and little changed on a QoQ basis from $3.8 billion in Q4 2025.

Enovis (ENOV) has 17 years of Liabilities and Shareholders Equity data on file, last reported at $3.8 billion in Q2 2026.

  • Quarterly Liabilities and Shareholders Equity fell 21.39% year-over-year to $3.8 billion in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $17.1 billion (down 16.83% YoY) and the FY2025 annual result came in at $3.8 billion, down 18.73% from the prior year.
  • Liabilities and Shareholders Equity held at $3.8 billion in Q2 2026 per ENOV's latest filing, from $3.8 billion in the prior quarter.
  • Across five years, Liabilities and Shareholders Equity topped out at $5.6 billion in Q3 2024 and bottomed at $2.8 billion in Q2 2022.
  • The 5-year median for Liabilities and Shareholders Equity is $4.4 billion (2022), against an average of $4.5 billion.
  • The widest annual swing landed in 2022, when Liabilities and Shareholders Equity slumped 65.29%; it then jumped 53.56% in 2023.
  • Tracing ENOV's Liabilities and Shareholders Equity over 5 years: stood at $4.3 billion in 2022, then grew by 5.52% to $4.5 billion in 2023, then advanced by 4.64% to $4.7 billion in 2024, then declined by 18.73% to $3.8 billion in 2025, then fell by 0.06% to $3.8 billion in 2026.
  • Per Business Quant, the three latest ENOV Liabilities and Shareholders Equity figures stand at $3.8 billion (Q2 2026), $3.8 billion (Q4 2025), and $4.4 billion (Q4 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 110.43 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 46.29 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 91.49 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 44.35 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 13.32 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 31.92 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 6.63 Bn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 37.13 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 10.74 Bn
10 Enovis 1.25 Bn 1.22 Bn 365.49 Mn 3.83 Bn

Historic Data

Download Data 🔒
DateValue
Apr 3, 2026 3.83 Bn
Dec 31, 2025 3.83 Bn
Oct 3, 2025 4.43 Bn
Jul 4, 2025 5.02 Bn
Apr 4, 2025 4.88 Bn
Dec 31, 2024 4.72 Bn
Sep 27, 2024 5.55 Bn
Jun 28, 2024 5.44 Bn
Mar 29, 2024 5.48 Bn
Dec 31, 2023 4.51 Bn
Sep 29, 2023 4.40 Bn
Jun 30, 2023 4.44 Bn
Mar 31, 2023 4.30 Bn
Dec 31, 2022 4.27 Bn
Sep 30, 2022 4.44 Bn
Jul 1, 2022 4.50 Bn
Apr 1, 2022 2.80 Bn
Dec 31, 2021 8.52 Bn
Oct 1, 2021 7.97 Bn
Jul 2, 2021 7.56 Bn
Apr 2, 2021 8.07 Bn
Dec 31, 2020 7.35 Bn
Oct 2, 2020 7.15 Bn
Jul 3, 2020 7.12 Bn
Apr 3, 2020 7.46 Bn
Dec 31, 2019 7.39 Bn
Sep 27, 2019 9.59 Bn
Jun 28, 2019 9.90 Bn
Mar 29, 2019 10.50 Bn
Dec 31, 2018 6.62 Bn
Sep 28, 2018 6.45 Bn
Jun 29, 2018 6.46 Bn
Dec 31, 2017 6.71 Bn
Sep 29, 2017 6.84 Bn
Jun 30, 2017 6.73 Bn
Mar 31, 2017 6.43 Bn
Dec 31, 2016 6.34 Bn
Sep 30, 2016 6.54 Bn
Jul 1, 2016 6.58 Bn
Apr 1, 2016 6.72 Bn
Dec 31, 2015 6.73 Bn
Sep 25, 2015 7.04 Bn
Jun 26, 2015 7.01 Bn
Mar 27, 2015 6.95 Bn
Dec 31, 2014 7.21 Bn
Sep 26, 2014 7.53 Bn
Jun 27, 2014 7.93 Bn
Mar 28, 2014 6.77 Bn
Dec 31, 2013 6.60 Bn
Sep 27, 2013 6.33 Bn
Jun 28, 2013 6.09 Bn
Mar 29, 2013 5.85 Bn
Dec 31, 2012 6.15 Bn
Sep 28, 2012 6.06 Bn
Jun 29, 2012 6.00 Bn
Mar 30, 2012 6.13 Bn
Dec 31, 2011 1.09 Bn
Sep 30, 2011 1.04 Bn
Jul 1, 2011 1.06 Bn
Dec 31, 2010 1.02 Bn